Investors

Corporate Profile

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam® drug delivery technology, for use in hospitals and ambulatory surgery centers.

Contact Pacira Investor Relations

For investor relations inquiries, please contact
Susan Mesco
(973) 451-4030
Susan.Mesco@pacira.com

Stock Quote

NASDAQ: PCRXData as of 12/14/174:00 p.m. ET
44.70USD - 1.1 (2.40%)
Volume | 298,127

refresh Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
View Our Latest Investor Presentation

Receive Email Alerts from Pacira

Sign up here to receive alerts

Sign up to automatically receive free Pacira Pharmaceuticals, Inc. financial information by email. Once signed up, you may choose from the following options:

  • Pacira Pharmaceuticals, Inc. SEC Filings Alert
  • Pacira Pharmaceuticals, Inc. News Alert

You may change your email options at any time, or opt out if desired.